Discovery of potential dual-target prodrugs of HIV-1 reverse transcriptase and nucleocapsid protein 7.

[1]  Qigui Yu,et al.  Potential Tools for Eradicating HIV Reservoirs in the Brain: Development of Trojan Horse Prodrugs for the Inhibition of P-Glycoprotein with Anti-HIV-1 Activity , 2019, Journal of medicinal chemistry.

[2]  E. Clercq.  Fifty Years in Search of Selective Antiviral Drugs , 2019 .

[3]  J. Deschamps,et al.  Reaction Kinetics Direct a Rational Synthesis of an HIV-1 Inactivator of Nucleocapsid Protein 7 and Provide Mechanistic Insight into Cellular Metabolism and Antiviral Activity. , 2018, Chemistry.

[4]  E. De Clercq,et al.  Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus. , 2018, European journal of medicinal chemistry.

[5]  E. De Clercq,et al.  First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain. , 2018, Bioorganic & medicinal chemistry letters.

[6]  S. de Castro,et al.  Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination therapy? , 2018, European journal of medicinal chemistry.

[7]  O. Tabarrini,et al.  NCp7: targeting a multitasking protein for next-generation anti-HIV drug development part 1: covalent inhibitors. , 2017, Drug discovery today.

[8]  A. Wang,et al.  Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus , 2016, Antiviral Research.

[9]  Peng Zhan,et al.  Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends. , 2016, Journal of medicinal chemistry.

[10]  P. Zhan,et al.  [Research progress of dual inhibitors targeting HIV-1 reverse transcriptase and integrase]. , 2013, Yao xue xue bao = Acta pharmaceutica Sinica.

[11]  X Liu,et al.  Rationally designed multitarget anti-HIV agents. , 2013, Current medicinal chemistry.

[12]  K. Anderson,et al.  Nucleocapsid protein annealing of a primer-template enhances (+)-strand DNA synthesis and fidelity by HIV-1 reverse transcriptase. , 2012, Journal of molecular biology.

[13]  E. Appella,et al.  Small-molecule inactivation of HIV-1 NCp7 by repetitive intracellular acyl transfer. , 2010, Nature chemical biology.

[14]  Li Huang,et al.  Betulinic acid derivatives as human immunodeficiency virus type 2 (HIV-2) inhibitors. , 2009, Journal of medicinal chemistry.

[15]  Peng Zhan,et al.  Designed multiple ligands: an emerging anti-HIV drug discovery paradigm. , 2009, Current pharmaceutical design.

[16]  Y. Pommier,et al.  Preferential Inhibition of the Magnesium-Dependent Strand Transfer Reaction of HIV-1 Integrase by α-Hydroxytropolones , 2006, Molecular Pharmacology.

[17]  P. T. Jørgensen,et al.  Synthesis and evaluation of double-prodrugs against HIV. Conjugation of D4T with 6-benzyl-1-(ethoxymethyl)-5-isopropyluracil (MKC-442, emivirine)-type reverse transcriptase inhibitors via the SATE prodrug approach. , 2005, Journal of medicinal chemistry.

[18]  H. W. Scheeren,et al.  Elongated multiple electronic cascade and cyclization spacer systems in activatible anticancer prodrugs for enhanced drug release. , 2001, The Journal of organic chemistry.

[19]  C. Nguyen,et al.  Synthesis and evaluation of "AZT-HEPT", "AZT-pyridinone", and "ddC-HEPT" conjugates as inhibitors of HIV reverse transcriptase. , 2000, Journal of medicinal chemistry.

[20]  H. W. Scheeren,et al.  Novel anthracycline-spacer-beta-glucuronide,-beta-glucoside, and -beta-galactoside prodrugs for application in selective chemotherapy. , 1999, Bioorganic & medicinal chemistry.

[21]  H. Langtry,et al.  Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. , 1989, Drugs.

[22]  C. Pannecouque,et al.  Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later , 2008, Nature Protocols.

[23]  A Ward,et al.  Pentoxifylline , 1987, Drugs.